ArticleInternational journal of clinical and experimental medicine2015

A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes.

Ran Xiong et al.PubMed ↗Full text ↗

No numbers read from the abstract.